Background: pre-evaluation of endogenous immunoglobulin levels is a potential strategy to improve the results of intravenous immunoglobulins in sepsis, but more work has to be done to identify those patients who could benefit the most from this treatment. The objective of this study was to evaluate the impact of endogenous immunoglobulins on the mortality risk in sepsis depending on disease severity.
Background
Pre-evaluation of endogenous immunoglobulin levels has been proposed as a potential tool to identify sepsis patients deserving replacement treatment with intravenous immunoglobulins (IVIG), to improve its results in this severe condition [1] .
Nonetheless, the impact of endogenous immunoglobulins levels on the risk of mortality in sepsis remains a controversial issue. A recent meta-analysis leaded by Shankar-Hari M found that the prevalence of IgG hypogamma-globulinaemia on the day of sepsis diagnosis is as high as 70%, but this finding did not identify a subgroup of patients with a higher risk of death [2] . Recently, results from the SBITs (Score-based immunoglobulin G therapy of patients with sepsis) study, showed that initial low IgG levels did not discriminate between survival and non-survival in patients with severe sepsis and septic shock [3] . In addition, patients with the highest IgG levels (fourth quartile) showed a statistically significant higher mortality in a risk-adjusted calculation compared to the reference quartile [3] . A previous report from our group supported that the answer could be in considering immunoglobulin isotypes not as isolated entities but in evaluating their prognostic ability in combination [4] [5] .
There are a number of factors that in our opinion have not been appropriately addressed in the studies evaluating the predictive ability of immunoglobulins: 1) we have demonstrated in a recent article that disease severity strongly influences biomarker performance in sepsis [6] ; 2) the influence of previous immunosupression has not been evaluated [5] ; 3) the impact of immunoglobulins on hospital mortality has not been sufficiently studied, with the majority of works being focused on the acute period of the disease [2] ; 4) finally, the ability of endogenous immunoglobulin levels to predict mortality in patients fulfilling the SEPSIS-3 criteria [7] [8] has not been reported to the present moment.
Aimed by the need of identifying patient subsets that could benefit the most from IVIG therapy, we have now evaluated the ability of endogenous immunoglobulins levels and also of a combined immunoglobulin score to predict mortality risk of sepsis patients fulfilling the SEPSIS-3 diagnostic criteria in two different scenarios of disease severity, at the short and the long term, with and without presence of previous immunosupression.
Methods
Study design: patients from two multi-center epidemiological studies on sepsis were merged to evaluate, in a retrospective manner, the association between levels of endogenous immunoglobulins in plasma and mortality depending on disease severity at ICU admission. 180 patients came from the GRECIA study [9] , (Grupo de Estudios y Análisis en Cuidados Intensivos) and 98 came from the ABISS-Edusepsis study (AntiBiotic Intervention in Severe Sepsis) [10] . In both studies, patients had sepsis at the time of admission to the ICU. For this study, only those patients fulfilling the new definition proposed by the SEPSIS-3 Consensus were considered [7] . Patients with human immunodeficiency virus (HIV) infection and those undergoing radiotherapy or receiving immunosuppressive drugs, including chemotherapy or systemic steroids, in the last 3 months prior to admission to the ICU were considered to be immunosuppressed. Exclusion criteria were cardiac arrest, therapeutic effort limitation and lack of informed consent. A common data sheet was developed to collect the clinical data, including medical history, physical examination and haematological, biochemical, radiological and microbiological investigations from the two studies. Treatment decisions were not standardized for all patients but were made by the treating physician, always based upon the Surviving Sepsis Campaign guidelines recommendations.
Immunoglobulin quantification: a 5-mL sample of blood was collected in an EDTA tube from all patients in the first 12 hours following ICU admission. The blood was centrifuged, and plasma was obtained and stored at -80 °C until required for immunoglobulin quantification. Plasma levels of immunoglobulins were measured using a multiplex immunoglobulin isotyping kit (Biorad TM, Hercules, CA, USA) on a Luminex platform. All plasma samples from the two studies (GRECIA and ABISS) were tested for immunoglobulin concentrations using the same equipment, to avoid potential bias due to multiplatform testing.
Statistical analysis:
for the demographic and clinical characteristics of the patients, differences between groups were assessed using the χ 2 test for categorical variables and the Mann-Whitney U test for continuous variables when appropriate. Patients were split into two groups based upon the percentile 50 for the Sequential Organ Failure Assessment (SOFA) score at ICU admission. In consequence, two groups of patients were generated (SOFA < 8 and SOFA > 8). Deciles of immunoglobulin concentrations were used to categorize patients below or above each decile, creating the corresponding categorical variables. Deciles were calculated for the entire cohort, since no differences for immunoglobulin levels were found between patients with SOFA score <8 and those with SOFA scores > 8 ( Table 1 ). We determined the occurrence of death in each severity group using Kaplan-Meier curves. Time was censored at day 28 following admission to the ICU for this analysis. The first decile showing significant differences between groups based on the log-rank test was considered as the immunoglobulin threshold. We established immuno-scores (ISC) for identifying those patients with the combined presence of low levels of two or more immunoglobulins (below each respective threshold). An overall score of 0 was assigned to all patients with levels below the thresholds for all immunoglobulins forming each immuno-score and a score 1 0 of 1 to the remaining patients. The dichotomous variables created for each immunoglobulin using the identified thresholds as well as the immuno-scores were further introduced into a multivariate logistic regression analysis to determine the association between immunoglobulin levels and the risk of mortality at the ICU and also at the hospital. Those variables of Table 1 yielding p values < 0.1 in the univariate analysis were considered as potential confounding factors and were further introduced in the multivariate one as adjusting variables. Data analysis was performed using SPSS for WINDOWS version 22.0 software (IBM-SPSS, Chicago, IL, USA).
Results

I. Clinical characteristics of the patients depending on disease severity at ICU
admission: in order to evaluate the potential differences between the patients included in the two severity groups, a descriptive table was built ( Table 1) . This table is important to find out whether or not patients` characteristics could explain the different results found for the two groups regarding the association between immunoglobulin levels and the risk of mortality, as showed later in this section. Table 1 shows that patients were elderly individuals, with the group of patients with SOFA score > 8 having a significant higher proportion of men. The most frequent co-morbidities found in both groups of patients were chronic cardiovascular disease, chronic respiratory disease, chronic renal failure and diabetes mellitus. The most severe group of patients showed a significant higher frequency of patients with history of chronic hepatic failure.
The proportion of patients with prior immunosupression did not differ in a significant manner between both groups. Sources of infection were similar in the two groups compared, with predominance of sepsis of respiratory, abdominal and urological origin.
Both groups presented also a similar proportion of infections caused by Gram + bacteria and fungi, but the most severe group had a significant higher frequency of infections caused by Gram -bacteria along with an overall higher frequency of patients with microbiologically confirmed infection. 94 % of the patients with SOFA > 8 presented with cardiovascular dysfunction, compared with 63% in the group of patients with SOFA < 8. As expected, patients in the most severe group showed higher APACHE-II scores, higher creatinine levels in plasma, and lower platelets counts in blood. In addition, mortality at the ICU and also at the hospital was markedly higher in this group. Immunoglobulin and albumin levels in plasma did not differ in a significant manner between both groups of patients. In those patients with positive microbiological identification, proportion of patients receiving appropriated antibiotic treatment based on the antibiogram results was similar between both severity groups (80% vs 73%, p = 0.420).
Clinical characteristics of the patients. Continuous variables are shown as median
(inter-quartile rank) and categorical variables as n (%). N.s: not significant. Figure 2 ). In addition, the ISC IgGAM failed to show any association with mortality in this analysis (Figure 2 ).
III. Regression analysis for prediction of mortality risk:
to evaluate the impact of the immunoglobulin thresholds on the mortality risk over the acute phase of the disease and also over the post-acute phase of the disease, regression analysis for predicting either ICU and hospital mortality were performed in the group of patients with SOFA < 8:
III.1 ICU mortality: we first compared the proportion of survivors and non survivors
at the ICU in the patients with immunoglobulin levels below/above these thresholds (Table 2) : Those thresholds showing differences at the level p < 0.1 in the Table 2 were further evaluated for their association with the risk of ICU mortality by using a multivariate analysis (Table 3 ). This analysis evidenced that exhibiting levels of IgG, IgG1 below their respective thresholds or having an ISC IgGAM = 0 was a robust, independent risk marker of ICU mortality. The highest Odds Ratio corresponded to the ISC IgGAM.
While the presence of patients with prior immunosupression did not affect the predictive ability of IgG, IgG1 and ISC IgGAM, it did influence IgG2, which was only able to predict mortality in those patients with no previous antecedents of immunosupression. The multivariate analysis confirmed that the ISC IgGAM was a strong predictor of the risk of hospital mortality, not affected by the presence of prior immunosupression (Table 5 ). Multivariate regression analysis for the ISCs combining two immunoglobulins were not performed since the vast majority of non survivors showing a "0" in the double ISCs showed also a "0" in the triple ISC (overlap with the triple score was 100% for ISC IgGM , of 90% for ISC IgGA and 82% for ISC IgMA).
Potential influence of hemodilution on the results: interestingly, hemodilution had no effect on the results observed in the less severe group of patients, as evidenced by the absence of significant correlation in the Spearman Test between levels of immunoglobulins and albumin concentration in plasma (p > 0.05).
Discussion
This study shows for the first time that the influence of endogenous immunoglobulin levels on the prognosis of patients with sepsis seems to be restricted to a subset of individuals presenting at the ICU with limited extent of organ failure. Our results evidenced also that the simultaneous presence of low levels of IgG, IgA and IgM was found to be a consistent predictor of both acute mortality (at the ICU) and post-acute mortality (at the hospital) in these patients, independently of the presence or absence of previous immunosupression. In contrast, the ability of total IgG or IgG1 to predict mortality was restricted to the acute period of the disease (ICU mortality). While the presence of patients with previous immunosupression did not alter the predictive ability of total IgG and IgG1, it modified that of IgG2, which was only able to predict ICU mortality in those patients with no previous immunosupression. These findings reinforce the superiority of the combined immunoglobulin score over immunoglobulins individually considered to identify sepsis patients at risk of poor outcomes [4] .
In the era of precision medicine in sepsis [11] [12], defining the immunological state of the patient will be crucial to the success of any biological response modifier for sepsis [13] [14] . Our findings could contribute to personalize treatment with IVIG in this disease. Failure of IVIG in demonstrating clinical benefit in sepsis [15] immunoglobulin preparation containing the three major immunoglobulin isotypes [21] .
As a major limitation of our study, immunoglobulins were measured in samples already available from the GRECIA and the ABISS studies, and in consequence it was retrospective in nature. This makes that sample size was not calculated based on a predefined primary outcome, which may represent a source of bias. Another limitation was the absence of lactate registries in many patients, which precluded identifying those patients fulfilling the new definition of septic shock as proposed by the SEPSIS-3 consensus [8] . In consequence, new prospective studies should confirm the results obtained in this work.
Conclusions
Results from this study suggest that endogenous immunoglobulin levels may have a different impact on the mortality risk of sepsis patients based on their severity. Future studies should be directed to investigate whether IVIG therapy may particularly benefit subsets of patients with moderate organ failure extent and low levels of the three immunoglobulin isotypes. 
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